Teladoc Health, Inc. (BMV:TDOC)

Teladoc Health Statistics

Total Valuation

Teladoc Health has a market cap or net worth of MXN 16.14 billion. The enterprise value is 20.60 billion.

Market Cap	16.14B
Enterprise Value	20.60B

Important Dates

The last earnings date was Wednesday, February 25, 2026.

Earnings Date	Feb 25, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	178.40M
Shares Outstanding	n/a
Shares Change (YoY)	+3.32%
Shares Change (QoQ)	+0.51%
Owned by Insiders (%)	1.09%
Owned by Institutions (%)	74.70%
Float	176.45M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.35
PB Ratio	0.65
P/TBV Ratio	n/a
P/FCF Ratio	3.14
P/OCF Ratio	3.05
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 25.76, with an EV/FCF ratio of 4.01.

EV / Earnings	-5.71
EV / Sales	0.47
EV / EBITDA	25.76
EV / EBIT	n/a
EV / FCF	4.01

Financial Position

The company has a current ratio of 2.77, with a Debt / Equity ratio of 0.75.

Current Ratio	2.77
Quick Ratio	2.43
Debt / Equity	0.75
Debt / EBITDA	22.38
Debt / FCF	3.64
Interest Coverage	-8.29

Financial Efficiency

Return on equity (ROE) is -13.93% and return on invested capital (ROIC) is -3.71%.

Return on Equity (ROE)	-13.93%
Return on Assets (ROA)	-3.20%
Return on Invested Capital (ROIC)	-3.71%
Return on Capital Employed (ROCE)	-6.66%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	8.89M
Profits Per Employee	-703,832
Employee Count	5,500
Asset Turnover	0.79
Inventory Turnover	20.21

Taxes

Income Tax	-633.86M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -54.74% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-54.74%
50-Day Moving Average	109.84
200-Day Moving Average	151.54
Relative Strength Index (RSI)	44.74
Average Volume (20 Days)	4,161

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	5.06

Income Statement

In the last 12 months, Teladoc Health had revenue of MXN 45.55 billion and -3.61 billion in losses. Loss per share was -20.47.

Revenue	45.55B
Gross Profit	31.66B
Operating Income	-2.94B
Pretax Income	-4.24B
Net Income	-3.61B
EBITDA	595.26M
EBIT	-2.94B
Loss Per Share	-20.47

Balance Sheet

The company has 14.06 billion in cash and 18.73 billion in debt, with a net cash position of -4.66 billion.

Cash & Cash Equivalents	14.06B
Total Debt	18.73B
Net Cash	-4.66B
Net Cash Per Share	n/a
Equity (Book Value)	24.95B
Book Value Per Share	139.90
Working Capital	12.86B

Cash Flow

In the last 12 months, operating cash flow was 5.30 billion and capital expenditures -160.10 million, giving a free cash flow of 5.14 billion.

Operating Cash Flow	5.30B
Capital Expenditures	-160.10M
Free Cash Flow	5.14B
FCF Per Share	n/a

Margins

Gross margin is 69.50%, with operating and profit margins of -6.46% and -7.92%.

Gross Margin	69.50%
Operating Margin	-6.46%
Pretax Margin	-9.31%
Profit Margin	-7.92%
EBITDA Margin	1.31%
EBIT Margin	-6.46%
FCF Margin	11.28%

Dividends & Yields

Teladoc Health does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-3.32%
Shareholder Yield	-3.32%
Earnings Yield	-22.34%
FCF Yield	31.83%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Teladoc Health has an Altman Z-Score of -6.46 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-6.46
Piotroski F-Score	4